Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-37,page-paged-37,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

CLIENT NEWS

 

 

  • Adrenomed completes full enrollment with 300 patients in AdrenOSS-2 trial with Adrecizumab in septic shock
    www.andrenomed.com
  • Biocrates Life Sciences AG and Helmholtz Zentrum München Celebrate 10 Years of Partnership in Personalized Medicine
    www.biocrates.com
  • APEIRON to present preclinical APN401 data at the 2019 ESMO Congress
    www.apeiron-biologics.com
  • Ergomed plc: Interim results for the six months ended 30 June 2019
    www.ergomedplc.com
  • Ergomed plc: Board Change
    www.ergomedplc.com
  • Apogenix AG: ESMO and Apogenix Collaborate on “Recurrent Glioblastoma Management: Challenges and Opportunities” Colloquium
    www.apogenix.com
  • Apogenix AG: Publication in Human Vaccines & Immunotherapeutics Illustrates the Advantages of Hexavalent CD40 Agonists in Targeting CD40 in Immuno-Oncology
    www.apogenix.com
  • Molecular Health to present at upcoming congresses
    www.molecularhealth.com
  • MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019)
    www.magforce.de
  • Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory
    www.veronapharma.com